Startseite › Adipositas › Florida › Orlando
Klinische Studien zu Adipositas in Orlando, FL
31 Studien zu Adipositas suchen Teilnehmer an Standorten in und um Orlando (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Teilnehmer gesuchtPhase 2
- Charter Research - Winter Park /ID# 281968, Orlando
- Florida Institute For Clinical Research /ID# 282739, Orlando
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese Patients
Teilnehmer gesucht
- Orlando Health, Inc., Orlando
A Study to Evaluate the Impact of Renal Impairment on the Pharmacokinetics (PK) of Ribupatide
Teilnehmer gesuchtPhase 1Gesunde Freiwillige willkommen
- Kailera Clinical Site, Orlando
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Teilnehmer gesuchtPhase 2
- Florida Institute For Clinical Research, LLC, Orlando
- K2 Medical Research - Maitland, Maitland · 6 mi entfernt
- Omega Research Orlando, Altamonte Springs · 9 mi entfernt
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
Teilnehmer gesuchtPhase 3
- Florida Institute for Clinical Research, LLC, Orlando
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Teilnehmer gesuchtPhase 2
- Clinical Site Partners, LLC DBA Flourish Research, Winter Park · 5 mi entfernt
- K2 Medical Research Maitland LLC, Main Office, Maitland · 6 mi entfernt
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Teilnehmer gesuchtPhase 2
- Clinical Neuroscience Solutions, Orlando
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Teilnehmer gesuchtPhase 3
- Clinical Neuroscience Solution, Orlando
- Florida Institute for Clinical Research, LLC, Orlando
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Teilnehmer gesuchtPhase 3
- Florida Inst For Clin Res LLC, Orlando
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Teilnehmer gesuchtPhase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Teilnehmer gesuchtPhase 3
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Teilnehmer gesuchtPhase 3
- Orlando Health, Orlando
- Digestive and Liver Center of Florida, Orlando
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Teilnehmer gesuchtPhase 3
- Clinical Neuroscience Solution, Orlando
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Teilnehmer gesuchtPhase 3
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi entfernt
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
Teilnehmer gesuchtPhase 3
- Research Site, Ocoee · 10 mi entfernt
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Teilnehmer gesuchtPhase 3
- West Orange Endocrinology, Ocoee · 10 mi entfernt
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
Teilnehmer gesuchtPhase 3
- Conquest Research, Winter Park · 5 mi entfernt
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
Teilnehmer gesuchtPhase 2
- Charter Research - Winter Park, Orlando
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Teilnehmer gesuchtPhase 3
- AURORA-1 Clinical Site, Winter Park · 5 mi entfernt
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Teilnehmer gesuchtPhase 3
- AURORA-2 Clinical Site, Winter Park · 5 mi entfernt
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Teilnehmer gesuchtPhase 3
- AdventHealth Orlando, Orlando
- Orlando Health Heart Institute, Orlando
- Guardian Research Organization LLC, Winter Park · 5 mi entfernt
- und 1 weitere
Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
Teilnehmer gesucht
- University of Central Florida, Orlando
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Teilnehmer gesuchtPhase 3Gesunde Freiwillige willkommen
- ACCOMPLISH-2 Research Site, Ocoee · 10 mi entfernt
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
Teilnehmer gesuchtPhase 2
- Charter Research - Winter Park, Orlando
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
Teilnehmer gesuchtPhase 3
- Kailera Clinical Site, Orlando
- Kailera Clinical Site, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Teilnehmer gesuchtPhase 3
- Clinical Neuroscience Solutions - Orlando, Orlando
- Combined Research Orlando Phase I IV, Orlando
- Florida Institute for Clinical Research, Orlando
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Teilnehmer gesuchtPhase 3
- Florida Institute for Clinical Research, Orlando
- Conquest Research - Winter Park, Winter Park · 5 mi entfernt
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
Teilnehmer gesuchtPhase 3
- Clinical Neuroscience Solutions, Orlando
- Florida Institute for Clinical Research, Orlando
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Teilnehmer gesuchtPhase 3
- Cardiovascular Institute of Orlando, Orlando
- Guardian Research Org LLC, Winter Park · 5 mi entfernt
- K2 Medical Research, Maitland · 6 mi entfernt
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Teilnehmer gesuchtPhase 3
- ACCOMPLISH-1 Research Site, Ocoee · 10 mi entfernt
Assessments of Adipogenesis, Lipid Turnover and Cellular Composition in Adipose Tissue in Response to Endurance Exercise
Teilnehmer gesuchtGesunde Freiwillige willkommen
- AdventHealth Translational Research Institute, Orlando
Adipositas-Studien in anderen Städten
- Houston, TX43 Studien
- Chicago, IL41 Studien
- New York City, NY40 Studien
- San Antonio, TX40 Studien
- Washington, DC33 Studien
- Dallas, TX30 Studien
- Boston, MA28 Studien
- Las Vegas, NV27 Studien
- Miami, FL27 Studien
- Baltimore, MD25 Studien
- Jacksonville, FL25 Studien
- St. Louis, MO25 Studien
Weitere Studien in Orlando
- Nichtkleinzelliges Lungenkarzinom44 Studien
- Metastasierender Krebs29 Studien
- Übergewicht27 Studien
- Alzheimer-Krankheit25 Studien
- Typ-2-Diabetes24 Studien
- Krebs (alle Arten)24 Studien
- Brustkrebs23 Studien
- Eierstockkrebs22 Studien
- Colitis ulcerosa22 Studien
- Lungenkrebs21 Studien
- Kolorektales Karzinom19 Studien
- Major Depression19 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 05.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.